Skip to main content
. 2018 May 30;9:373. doi: 10.3389/fneur.2018.00373

Table 1.

Demographic data.

Controls PD p-Value
N 50 95
% Female 38 32
Age (years) 67.8 (8.0) 68.7 (7.7) 0.947
Height (cm) 171.7 (9.8) 174.2 (10.2) 0.176
Mass (kg) 73.8 (14.6) 79.5 (15.2) 0.033
miniBEST 24.6 (2.2) 18.4 (4.7) <0.001
TUG time (s) 18.3 (3.1) 23.2 (10.0) 0.001
MoCA 26.8 (1.9) 25.5 (3.6) 0.019
SCOPA-COG 32.0 (3.5) 28.1 (5.6) <0.001
Fall in the past year (%) 12 38
Disease duration (years) 7.0 (5.2)
MDS-UPDRS part III 40.4 (12.9)
PIGD score 5.0 (3.2)
H&Y (range) 2–3
N with freezing of gait 26

Where applicable, groups were compared using independent sample t-tests and a significance level of 0.05.

Bold values indicate significant differences between PD and control subjects.

PD, Parkinson’s disease; miniBEST, mini Balance Evaluation Systems Test; MoCA, Montreal Cognitive Assessment; PIGD, Posture Instability and Gait Disability.